{"id":"W4415943874","doi":"10.1016/j.esmoop.2025.105833","title":"Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failure","year":2025,"lang":"en","type":"review","venue":"ESMO Open","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb","keywords":"Clinical trial; Nivolumab; Immunotherapy; Immune checkpoint; Cancer; PD-L1; Immune system; Antibody therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02269652,0.0005344694,0.002160908,0.002982779,0.0004392333,0.001609924,0.001018391,0.0006919321,0.003785797],"category_scores_gemma":[0.04210485,0.0001889156,0.005522431,0.002113586,0.0005305869,0.001790072,0.0008485452,0.001260843,0.0004938238],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001668426,"about_ca_system_score_gemma":0.003259965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001003587,"about_ca_topic_score_gemma":0.002309469,"domain_scores_codex":[0.9880679,0.005197645,0.003096458,0.001224428,0.001947668,0.0004658665],"domain_scores_gemma":[0.9576818,0.02533868,0.01165724,0.001413912,0.003304426,0.0006039732],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009956294,0.0005724289,0.07090671,0.06617717,0.01067782,0.0005744344,0.0005822691,0.002974645,0.002025016,0.001641013,0.005195249,0.828717],"study_design_scores_gemma":[0.00952632,0.04796031,0.498913,0.1612731,0.05201912,0.006092261,0.001741985,0.005864905,0.01119436,0.01352337,0.1915247,0.0003665431],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1930098,0.7761381,0.007882901,0.004126697,0.0007775846,0.002660804,0.003897722,0.0001415213,0.01136494],"genre_scores_gemma":[0.8367701,0.1463346,0.006366095,0.003258542,0.0008896803,0.002231475,0.003287587,0.00004605196,0.0008158843],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02269652,"threshold_uncertainty_score":0.1200321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04539532483745746,"score_gpt":0.377661229121693,"score_spread":0.3322659042842356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}